ROIV Competitors & Alternatives
Compare Roivant Sciences Ltd with similar stocks in the same industry
Biotechnology
ROIV
Main Stock$41.19
Tradestie Score
43
Market Cap
$10.76B
Revenue Growth
21.4%
Analyst Upside
+21.2%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARGX
argenx SE American Depositary Shares
|
$971.55
|
$46.96B | 33.3 | 47 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$424.00
|
$36.81B | 53.5 | 40 | Compare |
|
INSM
Insmed, Inc.
|
$119.49
|
$31.13B | - | 41 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$87.21
|
$24.57B | - | 63 | Compare |
|
GMAB
Genmab A/S ADS
|
$54.07
|
$19.56B | 47.7 | 32 | Compare |
|
INCY
Incyte Genomics Inc
|
$120.30
|
$16.93B | 62.2 | 53 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$69.45
|
$15.70B | 44.9 | 43 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$17.83
|
$15.22B | - | 45 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$256.55
|
$12.36B | 19.9 | 31 | Compare |
|
EXEL
Exelixis Inc
|
$70.58
|
$11.09B | 21.5 | 32 | Compare |
More ROIV Analysis
Data updated: Nov 10, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry